Smith & Nephew plc  

(Public, LON:SN)   Watch this stock  
Find more results for SN
1,033.00
-9.00 (-0.86%)
Jul 30 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1,023.00 - 1,049.00
52 week 737.50 - 1,136.00
Open 1,038.00
Vol / Avg. 1.59M/1.82M
Mkt cap 9.24B*
P/E 28.06
Div/yield 10.11/1.61*
EPS 0.37*
Shares 894.16M
Beta     -
Inst. own     -
*GBP
Aug 1, 2014
Q2 2014 Smith & Nephew PLC Earnings Call - 9:00AM GMT+1 - Add to calendar
Aug 1, 2014
Q2 2014 Smith & Nephew Earnings Release - 7:00AM GMT+1 - Add to calendar
Jun 20, 2014
Smith & Nephew PLC at Citi European Healthcare Conference
May 7, 2014
Smith & Nephew at Deutsche Bank Healthcare Conference
  

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 13.98% 12.78%
Operating margin 21.25% 18.62%
EBITD margin - 30.41%
Return on average assets 10.23% 9.70%
Return on average equity 14.56% 14.02%
Employees 11,036 -
CDP Score - 92 B

Address

15 Adam Street
LONDON, ENG WC2N 6LA
United Kingdom - Map
+44-20-74017646 (Phone)
+44-20-79303353 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (which includes arthroscopic procedures referred to as sports medicine) and advanced wound management. It operates in three segments: Orthopaedics, Endoscopy and Advanced Wound Management. It operates on a worldwide basis and has distribution channels in over 90 countries. Orthopaedic reconstruction implants include hip, knee and shoulder joints, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. Endoscopy business develops and commercialises endoscopic (minimally invasive surgery) techniques, educational programmes and services. Advanced Wound Management business offers a range of products from initial wound bed preparation through to full wound closure. In May 2012, it acquired Kalypto Medical, Inc. In May 2014, the Company acquired ArthroCare Corporation.

Officers and directors

Olivier Bohuon Chief Executive Officer, Executive Director
Age: 55
Julie Brown Chief Financial Officer, Executive Director
Age: 51
Rodrigo Bianchi President, IRAMEA
Age: 54
Michael G. Frazzette President - Advanced Surgical Devices
Age: 52
R. Gordon Howe President - Global Operations
Age: 51
Roger Teasdale President - Advanced Wound Management
Age: 46
Francisco Canal Vega President - Latin America
Age: 52
John W. Campo Chief Legal Officer
Age: 59
Helen Maye Chief Human Resources Officer
Age: 54
Cyrille Petit Chief Corporate Development Officer
Age: 43